Everolimus with reduced-exposure cyclosporine versus MMF and standard-exposure cyclosporine in de novo cardiac transplant recipients: 12-month results from a multicenter, Randomized trial

被引：0
|
作者：
Arizon, Jose [1 ]
Lehmkuhl, Hans [1 ]
Livi, Ugolino [1 ]
Vigano, Mario [1 ]
Branzi, Angelo [1 ]
Almenar, Luis [1 ]
Gerosa, Gino [1 ]
Musumeci, Francesco [1 ]
Vamous, Shaida [1 ]
Maccherini, Massimo [1 ]
Hexham, Mark [1 ]
Mange, Kevin C. [1 ]
机构：
[1] Hosp Univ Reina Sofia, Cordoba, Spain
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2008年 / 8卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：211 / 211
页数：1
相关论文
共 50 条
  • [1] Results of a 12-month, multicenter, randomized trial of everolimus with reduced-exposure cyclosporine versus MMF and standard-exposure cyclosporine in De Novo cardiac transplant recipients
    Lebmkuhl, H.
    Livi, U.
    Arizon, J.
    Vigano, M.
    Magelli, C.
    Boissonnat, P.
    Gerosa, G.
    Musumeci, F.
    Gandjbakhch, I.
    Vanhaecke, J.
    Hexham, J. M.
    Mange, K. C.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2008, 27 (02): : S65 - S65
  • [2] Everolimus and reduced-exposure cyclosporine vs mmf and standard-expsosure cyclosporine:: 12-month results in DE NOVO cardiac transplant recipients
    Livi, Ugolino
    Lehmkuhl, Hans
    Arizon, Jose
    Vigano, Mario
    Magelli, Carlo
    Boissonnat, Pascale
    Gerosa, Gino
    Musumeci, Francesco
    Gandjbakhch, Iradj
    Vanhaecke, Johan
    Abeywickrama, Kamal
    [J]. TRANSPLANT INTERNATIONAL, 2007, 20 : 93 - 94
  • [3] Everolimus with reduced-exposure cyclosporine in de novo heart transplant patients: 6-month results of a multicenter, randomized trial.
    Zuckermann, A.
    Wang, S. S.
    Keogh, A.
    Ross, H.
    Frigerio, M.
    Eisen, H.
    Bara, C.
    Laufer, G.
    Cotrufo, M.
    Lena, S.
    Sips, C.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 443 - 443
  • [4] Everolimus With Reduced Cyclosporine Versus MMF With Standard Cyclosporine in De Novo Heart Transplant Recipients
    Lehmkuhl, Hans B.
    Arizon, Jose
    Vigano, Mario
    Almenar, Luis
    Gerosa, Gino
    Maccherini, Massimo
    Varnous, Shaida
    Musumeci, Francesco
    Hexham, J. Mark
    Mange, Kevin C.
    Livi, Ugolino
    [J]. TRANSPLANTATION, 2009, 88 (01) : 115 - 122
  • [5] 12-month safety and efficacy of everolimus with reduced exposure cyclosporine in de novo renal transplant recipients
    Tedesco-Silva, Helio, Jr.
    Vitko, Stefan
    Pascual, Julio
    Eris, Josette
    Magee, John C.
    Whelchel, John
    Civati, Giovanni
    Campbell, Scott
    Alves-Filho, Gentil
    Bourbigot, Bernard
    Garcia, Valter Duro
    Leone, John
    Esmeraldo, Ronaldo
    Rigotti, Paolo
    Cambi, Vincenzo
    Haas, Tomas
    [J]. TRANSPLANT INTERNATIONAL, 2007, 20 (01) : 27 - 36
  • [6] Everolimus with reduced cyclosporine exposure vs. MMF and conventional cyclosporine:: Results from a study in de novo heart transplant recipients
    Lehmkuhl, H.
    Livi, U.
    Boissonnat, P.
    Arizon, J.
    Vigano, M.
    Magelli, C.
    Almenar, L.
    Abeywickrama, K. H.
    Gezabegen, Y.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2007, 26 (02): : S202 - S202
  • [7] De novo therapy with everolimus and reduced-exposure cyclosporine following pediatric kidney transplantation: A prospective, multicenter, 12-month study
    Grushkin, Carl
    Mahan, John D.
    Mange, Kevin C.
    Hexham, J. Mark
    Ettenger, Robert
    [J]. PEDIATRIC TRANSPLANTATION, 2013, 17 (03) : 237 - 243
  • [8] EFFICACY AND SAFETY OF EVEROLIMUS WITH REDUCED-EXPOSURE CYCLOSPORINE IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS: 24-MONTH ANALYSIS FROM THE TRANSFORM STUDY
    Sommerer, Claudia
    Pinchuk, Aleksey
    Aleman, Silvina
    Vuiblet, Vincent
    Van der Giet
    Amante, Angel Joaquin
    Han, Duck Jong
    Huynh-Do, Uyen
    Ingsathit, Atiporn
    Gawai, Apurva
    Gutierrez, Maria Pilar Hernandez
    Carmellini, Mario
    [J]. TRANSPLANTATION, 2020, 104 (09) : S622 - S623
  • [9] Safety and Efficacy of the Early Introduction of Everolimus With Reduced-Exposure Cyclosporine A in De Novo Kidney Recipients
    Oh, Chang-Kwon
    Huh, Kyu Ha
    Ha, Jongwon
    Kim, Yeong Hoon
    Kim, Yong-Lim
    Kim, Yu Seun
    [J]. TRANSPLANTATION, 2015, 99 (01) : 180 - 186
  • [10] Hospitalization days due to Major cardiac events (MACE) in De Novo heart transplant recipients:: Data from a 12-month, multicenter, randomized trial of everolimus versus MMF
    Lebmkuhl, H.
    Arizon, J.
    Almentar, L.
    Magelli, C.
    Gerosa, G.
    Varnous, S.
    Musumeci, F.
    Mattei, M. -F.
    Vanbaecke, J.
    Mange, K.
    Machnicki, G.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2008, 27 (02): : S228 - S228
12345